Key result
Women with ischemic stroke had slightly lower odds of receiving defect-free care than men (OR 0.96; 95% CI 0.93-1.00) and were less likely to receive thrombolysis (OR 0.92; P=0.02).
Why the study?
Does female sex affect the receipt of defect-free care and thrombolysis in patients with ischemic stroke?
Observational (n=51,317)
Yes
Does female sex affect the receipt of defect-free care and thrombolysis in patients with ischemic stroke?
Odds Ratio: 0.96 (95% CI 0.93–1)
While overall defect-free care for ischemic stroke is comparable between sexes, women are significantly less likely to receive thrombolysis and achieve door-to-needle times under 1 hour.
Sex disparities in stroke metrics may persist; leaves open whether equity interventions improve thrombolysis rates in women.
BACKGROUND AND PURPOSE: Sex-specific disparities in stroke care including thrombolytic therapy and early hospital admission are reported. In a large registry of Florida and Puerto Rico hospitals participating in the Get With The Guidelines-Stroke program, we sought to determine sex-specific differences in ischemic stroke performance metrics and overall thrombolytic treatment. METHODS: Around 51 317 (49% women) patients were included from 73 sites from 2010 to 2014. Multivariable logistic regression with generalized estimating equations evaluated sex-specific differences in the prespecified Get With The Guidelines-Stroke metrics for defect-free care in ischemic stroke, adjusting for age, race-ethnicity, insurance status, hospital characteristics, individual risk factors, and the presenting stroke severity. RESULTS: As compared with men, women were older (73±15 versus 69±14 years; P<0.0001), more hypertensive (67% versus 63%, P<0.0001), and had more atrial fibrillation (19% versus 16%; P<0.0001). Defect-free care was slightly lower in women than in men (odds ratio, 0.96; 95% confidence interval, 0.93-1.00). Temporal trends in defect-free care improved substantially and similarly for men and women, with a 29% absolute improvement in women (P<0.0001) and 28% in men (P<0.0001), with P value of 0.13 for time-by-sex interaction. Women were less likely to receive thrombolysis (odds ratio, 0.92; 95% confidence interval, 0.86-0.99; P=0.02) and less likely to have a door-to-needle time <1 hour (odds ratio, 0.83; 95% confidence interval, 0.71-0.97; P=0.02) as compared with men. CONCLUSIONS: Women received comparable stroke care to men in this registry as measured by prespecified Get With The Guidelines metrics. However, women less likely received thrombolysis and had door-to-needle time <1 hour, an observation that calls for the implementation of interventions to reduce sex disparity in these measures.
No takes yet. Share an insight, caveat, or question.
Asdaghi et al. (2016) conducted an observational in Ischemic stroke (n=51,317). Female sex vs. Male sex was evaluated on Defect-free care in ischemic stroke (OR 0.96, 95% CI 0.93-1.00). Women with ischemic stroke had slightly lower odds of receiving defect-free care than men (OR 0.96; 95% CI 0.93-1.00) and were less likely to receive thrombolysis (OR 0.92; P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: